Journal of Clinical Endocrinology & Metabolism, Vol 68, 364-368, Copyright © 1989 by Endocrine Society

ARTICLES

Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women

JL Stock, JA Coderre, B McDonald and LJ Rosenwasser
Endocrinology Research Laboratory, Worcester Memorial Hospital, Massachusetts 01605.

Estrogen (E) inhibits bone resorption, but the mechanism of this effect is unknown. Interleukin-1 (IL-1) stimulates bone resorption in vitro and may be produced in bone by mononuclear phagocytes. Recently, the spontaneous release of IL-1 from peripheral monocytes was found to reflect bone formation in a subset of patients with idiopathic osteoporosis. We suspected that the action of E on bone is mediated indirectly by its effect on monocyte IL-1 activity. Eleven normal postmenopausal women taking no medications were given conjugated E (0.625 mg daily) for 3-9 weeks. Supernatants from cultured peripheral monocytes were analyzed for IL-1 production by stimulation of a cloned murine helper T-cell line. IL-1 release was expressed as a percentage of maximum release corrected for monocyte number. IL-1 release before E treatment was 11.0 +/- 0.2% (+/- SE), it was 7.8 +/- 1.6% after E treatment (P = NS). IL-1 release fell in each of the three women with the highest initial values (46% to 5%, 25% to 17%, and 18% to 12%). IL- 1 release did not correlate with serum osteocalcin or fasting urinary calcium either before or after E treatment. Addition of 10(-7)-10(-10) mol/L 17 beta-estradiol to cultured monocytes obtained before E treatment caused an increase in IL-1 release that did not follow a dose- response relationship. Treatment of postmenopausal women with E did not affect spontaneous IL-1 release by peripheral monocytes in vitro. The addition of E in vitro did not produce consistent changes in IL-1 release by these cells. This does not exclude the possibility that E may affect monocyte IL-1 release in subsets of women with high spontaneous monocyte IL-1 release with or without osteoporosis.

This article has been cited by other articles:

				R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]

				A. Bouman, M. J. Heineman, and M. M. Faas Sex hormones and the immune response in humans Hum. Reprod. Update, July 1, 2005; 11(4): 411 - 423. [Abstract] [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				B. K. Pedersen and L. Hoffman-Goetz Exercise and the Immune System: Regulation, Integration, and Adaptation Physiol Rev, July 1, 2000; 80(3): 1055 - 1081. [Abstract] [Full Text] [PDF]

				N. Miyamoto, M. Mandai, I. Suzuma, K. Suzuma, K. Kobayashi, and Y. Honda Estrogen Protects Against Cellular Infiltration by Reducing the Expressions of E-Selectin and IL-6 in Endotoxin-Induced Uveitis J. Immunol., July 1, 1999; 163(1): 374 - 379. [Abstract] [Full Text] [PDF]

				K. K. Miller and A. Klibanski Amenorrheic Bone Loss J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1775 - 1783. [Full Text]

				C. H. Selzman, T. A. Whitehill, B. D. Shames, E. J. Pulido, B. C. Cain, and A. H. Harken The Biology of Estrogen-Mediated Repair of Cardiovascular Injury Ann. Thorac. Surg., March 1, 1998; 65(3): 868 - 874. [Abstract] [Full Text] [PDF]

				M. R. Adams, T. C. Register, D. L. Golden, J. D. Wagner, and J. K. Williams Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 217 - 221. [Abstract] [Full Text]

				S. H. Zuckerman and N. Bryan-Poole Estrogen-Induced Alterations in Lipoprotein Metabolism in Autoimmune MRL/lpr Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1556 - 1562. [Abstract] [Full Text]